Cenerimod's Development Targets Severe SLE Disease Activity
Novel S1P1 receptor modulator cenerimod shows impact on disease activity in lupus, with more pronounced benefits in those with more severe disease.
Source: medscape.com
Stay updated with breaking news from Sandra Navarra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novel S1P1 receptor modulator cenerimod shows impact on disease activity in lupus, with more pronounced benefits in those with more severe disease.
SLE had a greater impact on mortality and other poor outcomes than all the other comorbidities considered in a cross-sectional study of patients with COVID-19 in Brazil.